{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T18:09:08Z","timestamp":1788890948441,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"DOI":"10.1007\/s40120-026-01022-x","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T17:40:48Z","timestamp":1788889248000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cenobamate Improves Emotional Dysregulation, Impulsivity, and Apathy in Drug-Resistant Focal Epilepsy: A Longitudinal Neuropsychological Study"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4136-9245","authenticated-orcid":false,"given":"Ilaria","family":"Sammarra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1273-4519","authenticated-orcid":false,"given":"Adriana","family":"Saraceno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8964-8649","authenticated-orcid":false,"given":"Iolanda","family":"Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Vono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2444-8761","authenticated-orcid":false,"given":"Francesca Felicia","family":"Operto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8395-7809","authenticated-orcid":false,"given":"Francesco","family":"Fortunato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7384-3074","authenticated-orcid":false,"given":"Antonio","family":"Gambardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"1022_CR1","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S1474-4422(23)00151-5","volume":"22","author":"E Perucca","year":"2023","unstructured":"Perucca E, Perucca P, White HS, Wirrell EC. Drug resistance in epilepsy. Lancet Neurol. 2023;22:723\u201334. https:\/\/doi.org\/10.1016\/S1474-4422(23)00151-5.","journal-title":"Lancet Neurol"},{"key":"1022_CR2","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1111\/j.1528-1167.2005.00279.x","volume":"46","author":"PJ Thompson","year":"2005","unstructured":"Thompson PJ, Duncan JS. Cognitive decline in severe intractable epilepsy. Epilepsia. 2005;46:1780\u20137. https:\/\/doi.org\/10.1111\/j.1528-1167.2005.00279.x.","journal-title":"Epilepsia"},{"key":"1022_CR3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2015.243","volume":"12","author":"AM Kanner","year":"2016","unstructured":"Kanner AM. Management of psychiatric and neurological comorbidities in epilepsy. Nat Rev Neurol. 2016;12:106\u201316. https:\/\/doi.org\/10.1038\/nrneurol.2015.243.","journal-title":"Nat Rev Neurol"},{"key":"1022_CR4","doi-asserted-by":"publisher","first-page":"107073","DOI":"10.1016\/j.yebeh.2020.107073","volume":"107","author":"M Tombini","year":"2020","unstructured":"Tombini M, Assenza G, Quintiliani L, et al. Depressive symptoms and difficulties in emotion regulation in adult patients with epilepsy: association with quality of life and stigma. Epilepsy Behav. 2020;107:107073. https:\/\/doi.org\/10.1016\/j.yebeh.2020.107073.","journal-title":"Epilepsy Behav"},{"key":"1022_CR5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10862-008-9102-4","volume":"30","author":"KL Gratz","year":"2008","unstructured":"Gratz KL, Roemer L. Multidimensional assessment of emotion regulation and dysregulation: development, factor structure, and initial validation of the difficulties in emotion regulation scale. J Psychopathol Behav Assess. 2008;30:315\u2013315. https:\/\/doi.org\/10.1007\/s10862-008-9102-4.","journal-title":"J Psychopathol Behav Assess"},{"key":"1022_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.copsyc.2015.01.013","volume":"3","author":"NH Weiss","year":"2015","unstructured":"Weiss NH, Sullivan TP, Tull MT. Explicating the role of emotion dysregulation in risky behaviors: a review and synthesis of the literature with directions for future research and clinical practice. Curr Opin Psychol. 2015;3:22\u20139. https:\/\/doi.org\/10.1016\/j.copsyc.2015.01.013.","journal-title":"Curr Opin Psychol"},{"key":"1022_CR7","doi-asserted-by":"publisher","first-page":"106997","DOI":"10.1016\/j.eplepsyres.2022.106997","volume":"186","author":"S-A Lee","year":"2022","unstructured":"Lee S-A, Yang H, Im K, et al. Comparisons of impulsivity among patients with different subtypes of epilepsy. Epilepsy Res. 2022;186:106997. https:\/\/doi.org\/10.1016\/j.eplepsyres.2022.106997.","journal-title":"Epilepsy Res"},{"key":"1022_CR8","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1176\/appi.ajp.158.11.1783","volume":"158","author":"FG Moeller","year":"2001","unstructured":"Moeller FG, Barratt ES, Dougherty DM, Schmitz JM, Swann AC. Psychiatric aspects of impulsivity. AJP. 2001;158:1783\u201393. https:\/\/doi.org\/10.1176\/appi.ajp.158.11.1783.","journal-title":"AJP"},{"key":"1022_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/ab.20387","volume":"37","author":"K Derefinko","year":"2011","unstructured":"Derefinko K, DeWall CN, Metze AV, Walsh EC, Lynam DR. Do different facets of impulsivity predict different types of aggression? Aggr Behav. 2011;37:223\u201333. https:\/\/doi.org\/10.1002\/ab.20387.","journal-title":"Aggr Behav"},{"key":"1022_CR10","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.yebeh.2011.09.004","volume":"22","author":"GNM De Oliveira","year":"2011","unstructured":"De Oliveira GNM, Kummer A, Salgado JV, Filho GMDA, David AS, Teixeira AL. Suicidality in temporal lobe epilepsy: measuring the weight of impulsivity and depression. Epilepsy Behav. 2011;22:745\u20139. https:\/\/doi.org\/10.1016\/j.yebeh.2011.09.004.","journal-title":"Epilepsy Behav"},{"key":"1022_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.psychres.2007.06.002","volume":"158","author":"IHA Franken","year":"2008","unstructured":"Franken IHA, Van Strien JW, Nijs I, Muris P. Impulsivity is associated with behavioral decision-making deficits. Psychiatry Res. 2008;158:155\u201363. https:\/\/doi.org\/10.1016\/j.psychres.2007.06.002.","journal-title":"Psychiatry Res"},{"key":"1022_CR12","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.seizure.2017.08.003","volume":"51","author":"J-G Seo","year":"2017","unstructured":"Seo J-G, Lee G-H, Park S-P. Apathy in people with epilepsy and its clinical significance: a case\u2013control study. Seizure. 2017;51:80\u20136. https:\/\/doi.org\/10.1016\/j.seizure.2017.08.003.","journal-title":"Seizure"},{"key":"1022_CR13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1176\/jnp.17.1.7","volume":"17","author":"R Van Reekum","year":"2005","unstructured":"Van Reekum R, Stuss DT, Ostrander L. Apathy: why care? J Neuropsychiatry Clin Neurosci. 2005;17:7\u201319. https:\/\/doi.org\/10.1176\/jnp.17.1.7.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"1022_CR14","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41582-021-00555-z","volume":"17","author":"BP Hermann","year":"2021","unstructured":"Hermann BP, Struck AF, Busch RM, Reyes A, Kaestner E, McDonald CR. Neurobehavioural comorbidities of epilepsy: towards a network-based precision taxonomy. Nat Rev Neurol. 2021;17:731\u201346. https:\/\/doi.org\/10.1038\/s41582-021-00555-z.","journal-title":"Nat Rev Neurol"},{"key":"1022_CR15","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1080\/14656566.2017.1309025","volume":"18","author":"J-A Witt","year":"2017","unstructured":"Witt J-A, Helmstaedter C. How can we overcome neuropsychological adverse effects of antiepileptic drugs? Expert Opin Pharmacother. 2017;18:551\u20134. https:\/\/doi.org\/10.1080\/14656566.2017.1309025.","journal-title":"Expert Opin Pharmacother"},{"key":"1022_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.yebeh.2017.08.039","volume":"76","author":"B Chen","year":"2017","unstructured":"Chen B, Choi H, Hirsch LJ, et al. Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy. Epilepsy Behav. 2017;76:24\u201331. https:\/\/doi.org\/10.1016\/j.yebeh.2017.08.039.","journal-title":"Epilepsy Behav"},{"key":"1022_CR17","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1016\/j.euroneuro.2015.07.027","volume":"25","author":"J-A Witt","year":"2015","unstructured":"Witt J-A, Elger CE, Helmstaedter C. Adverse cognitive effects of antiepileptic pharmacotherapy: each additional drug matters. Eur Neuropsychopharmacol. 2015;25:1954\u20139. https:\/\/doi.org\/10.1016\/j.euroneuro.2015.07.027.","journal-title":"Eur Neuropsychopharmacol"},{"key":"1022_CR18","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.yebeh.2012.09.015","volume":"26","author":"J-A Witt","year":"2013","unstructured":"Witt J-A, Helmstaedter C. Monitoring the cognitive effects of antiepileptic pharmacotherapy\u2014approaching the individual patient. Epilepsy Behav. 2013;26:450\u20136. https:\/\/doi.org\/10.1016\/j.yebeh.2012.09.015.","journal-title":"Epilepsy Behav"},{"key":"1022_CR19","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2025.5625","author":"E Cerulli Irelli","year":"2026","unstructured":"Cerulli Irelli E, Roberti R, Borioni MS, et al. Comparative effectiveness of brivaracetam, cenobamate, lacosamide, and perampanel in focal epilepsy. JAMA Neurol. 2026. https:\/\/doi.org\/10.1001\/jamaneurol.2025.5625.","journal-title":"JAMA Neurol"},{"key":"1022_CR20","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s40120-024-00634-5","volume":"13","author":"S Lattanzi","year":"2024","unstructured":"Lattanzi S, Ranzato F, Di Bonaventura C, et al. Effectiveness and safety of adjunctive cenobamate in people with focal-onset epilepsy: evidence from the first interim analysis of the BLESS study. Neurol Ther. 2024;13:1203\u201317. https:\/\/doi.org\/10.1007\/s40120-024-00634-5.","journal-title":"Neurol Ther"},{"key":"1022_CR21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/epi4.12857","volume":"9","author":"J Catal\u00e1n-Aguilar","year":"2024","unstructured":"Catal\u00e1n-Aguilar J, Hampel KG, Cano-L\u00f3pez I, et al. Prospective study of cenobamate on cognition, affectivity, and quality of life in focal epilepsy. Epilepsia Open. 2024;9:223\u201335. https:\/\/doi.org\/10.1002\/epi4.12857.","journal-title":"Epilepsia Open"},{"key":"1022_CR22","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s40120-025-00859-y","volume":"15","author":"T Ramirez-Garcia","year":"2026","unstructured":"Ramirez-Garcia T, Cabezudo-Garcia P, Garcia-Martin G, et al. Long-term impact of cenobamate on cognition in patients with drug-resistant focal epilepsy: outcomes from an exploratory real-world study. Neurol Ther. 2026;15:193\u2013211. https:\/\/doi.org\/10.1007\/s40120-025-00859-y.","journal-title":"Neurol Ther"},{"key":"1022_CR23","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s40263-025-01196-2","volume":"39","author":"J-A Witt","year":"2025","unstructured":"Witt J-A, Badr M, Surges R, Von Wrede R, Helmstaedter C. The effects of cenobamate and its dosage on cognition: a retrospective longitudinal study in 84 individuals with epilepsy. CNS Drugs. 2025;39:893\u2013902. https:\/\/doi.org\/10.1007\/s40263-025-01196-2.","journal-title":"CNS Drugs"},{"key":"1022_CR24","doi-asserted-by":"publisher","first-page":"110838","DOI":"10.1016\/j.yebeh.2025.110838","volume":"175","author":"M Ferlisi","year":"2026","unstructured":"Ferlisi M, Trespidi C, Zivelonghi C, Bonetti B, Zanoni T. Psychiatric effects of cenobamate in adults with epilepsy: a retrospective study. Epilepsy Behav. 2026;175:110838. https:\/\/doi.org\/10.1016\/j.yebeh.2025.110838.","journal-title":"Epilepsy Behav"},{"key":"1022_CR25","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1111\/epi.18091","volume":"65","author":"R Roberti","year":"2024","unstructured":"Roberti R, Assenza G, Bisulli F, et al. Adjunctive cenobamate in people with focal onset seizures: insights from the Italian expanded access program. Epilepsia. 2024;65:2909\u201322. https:\/\/doi.org\/10.1111\/epi.18091.","journal-title":"Epilepsia"},{"key":"1022_CR26","doi-asserted-by":"publisher","first-page":"110913","DOI":"10.1016\/j.yebeh.2026.110913","volume":"176","author":"M Karatas","year":"2026","unstructured":"Karatas M, Yavuz A, Newman B, et al. Cenobamate\u2019s effect on mood and seizure frequency. Epilepsy Behav. 2026;176:110913. https:\/\/doi.org\/10.1016\/j.yebeh.2026.110913.","journal-title":"Epilepsy Behav"},{"key":"1022_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-026-00894-3","author":"FF Operto","year":"2026","unstructured":"Operto FF, Pastorino GMG, Charlier B, et al. Long-term impact of cenobamate on cognition, adaptive behavior, and quality of life in patients with tuberous sclerosis complex. Neurol Ther. 2026. https:\/\/doi.org\/10.1007\/s40120-026-00894-3.","journal-title":"Neurol Ther"},{"key":"1022_CR28","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E Von Elm","year":"2008","unstructured":"Von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344\u20139. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.11.008.","journal-title":"J Clin Epidemiol"},{"key":"1022_CR29","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1111\/epi.18338","volume":"66","author":"S Beniczky","year":"2025","unstructured":"Beniczky S, Trinka E, Wirrell E, et al. Updated classification of epileptic seizures: position paper of the International League Against Epilepsy. Epilepsia. 2025;66:1804\u201323. https:\/\/doi.org\/10.1111\/epi.18338.","journal-title":"Epilepsia"},{"key":"1022_CR30","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","volume":"51","author":"P Kwan","year":"2010","unstructured":"Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51:1069\u201377. https:\/\/doi.org\/10.1111\/j.1528-1167.2009.02397.x.","journal-title":"Epilepsia"},{"key":"1022_CR31","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington: American Psychiatric Publishing; 2013.","edition":"5"},{"key":"1022_CR32","unstructured":"European Medicines Agency. ONTOZRY: Summary of Product Characteristics. Amsterdam: European Medicines Agency; 2021. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/ontozry-epar-product-information_en.pdf. Accessed 3 Jun 2026."},{"key":"1022_CR33","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. ATC\/DDD Index 2022. 2021. https:\/\/www.whocc.no\/atc_ddd_index\/. Accessed 3 Jun 2026."},{"key":"1022_CR34","doi-asserted-by":"publisher","first-page":"108600","DOI":"10.1016\/j.yebeh.2022.108600","volume":"128","author":"I Sammarra","year":"2022","unstructured":"Sammarra I, Martino I, Caligiuri ME, et al. The impact of one-year COVID-19 containment measures in patients with mesial temporal lobe epilepsy: a longitudinal survey-based study. Epilepsy Behav. 2022;128:108600. https:\/\/doi.org\/10.1016\/j.yebeh.2022.108600.","journal-title":"Epilepsy Behav"},{"key":"1022_CR35","doi-asserted-by":"publisher","first-page":"111110","DOI":"10.1016\/j.yebeh.2026.111110","volume":"182","author":"I Sammarra","year":"2026","unstructured":"Sammarra I, Martino I, Vono A, et al. Evaluating personality pathological profiles in temporal lobe epilepsy and functional seizures according to DSM-5 alternative model for personality disorders. Epilepsy Behav. 2026;182:111110. https:\/\/doi.org\/10.1016\/j.yebeh.2026.111110.","journal-title":"Epilepsy Behav"},{"key":"1022_CR36","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1","volume":"51","author":"JH Patton","year":"1995","unstructured":"Patton JH, Stanford MS, Barratt ES. Factor structure of the Barratt impulsiveness scale. J Clin Psychol. 1995;51:768\u201374. https:\/\/doi.org\/10.1002\/1097-4679(199511)51:6%3c768::AID-JCLP2270510607%3e3.0.CO;2-1.","journal-title":"J Clin Psychol"},{"key":"1022_CR37","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.paid.2009.04.008","volume":"47","author":"MS Stanford","year":"2009","unstructured":"Stanford MS, Mathias CW, Dougherty DM, Lake SL, Anderson NE, Patton JH. Fifty years of the Barratt impulsiveness scale: an update and review. Personal Individ Differ. 2009;47:385\u201395. https:\/\/doi.org\/10.1016\/j.paid.2009.04.008.","journal-title":"Personal Individ Differ"},{"key":"1022_CR38","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0165-1781(91)90040-V","volume":"38","author":"RS Marin","year":"1991","unstructured":"Marin RS, Biedrzycki RC, Firinciogullari S. Reliability and validity of the apathy evaluation scale. Psychiatry Res. 1991;38:143\u201362. https:\/\/doi.org\/10.1016\/0165-1781(91)90040-V.","journal-title":"Psychiatry Res"},{"key":"1022_CR39","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1528-1157.1998.tb01278.x","volume":"39","author":"JA Cramer","year":"1998","unstructured":"Cramer JA, Perrine K, Devinsky O, Bryant-Comstock L, Meador K, Hermann B. Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory. Epilepsia. 1998;39:81\u20138. https:\/\/doi.org\/10.1111\/j.1528-1157.1998.tb01278.x.","journal-title":"Epilepsia"},{"key":"1022_CR40","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.intell.2018.01.003","volume":"67","author":"J Scharfen","year":"2018","unstructured":"Scharfen J, Peters JM, Holling H. Retest effects in cognitive ability tests: a meta-analysis. Intelligence. 2018;67:44\u201366. https:\/\/doi.org\/10.1016\/j.intell.2018.01.003.","journal-title":"Intelligence"},{"key":"1022_CR41","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul F, Erdfelder E, Lang A-G, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39:175\u201391. https:\/\/doi.org\/10.3758\/BF03193146.","journal-title":"Behav Res Methods"},{"key":"1022_CR42","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s40263-021-00819-8","volume":"35","author":"R Roberti","year":"2021","unstructured":"Roberti R, De Caro C, Iannone LF, Zaccara G, Lattanzi S, Russo E. Pharmacology of cenobamate: mechanism of action, pharmacokinetics, drug\u2013drug interactions and tolerability. CNS Drugs. 2021;35:609\u201318. https:\/\/doi.org\/10.1007\/s40263-021-00819-8.","journal-title":"CNS Drugs"},{"key":"1022_CR43","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s11065-007-9043-9","volume":"17","author":"DW Loring","year":"2007","unstructured":"Loring DW, Marino S, Meador KJ. Neuropsychological and behavioral effects of antiepilepsy drugs. Neuropsychol Rev. 2007;17:413\u201325. https:\/\/doi.org\/10.1007\/s11065-007-9043-9.","journal-title":"Neuropsychol Rev"},{"key":"1022_CR44","doi-asserted-by":"publisher","DOI":"10.1177\/15357597241242250","author":"J Stern","year":"2024","unstructured":"Stern J, Stanton S, Howe-Martin L, et al. The multidisciplinary team in the treatment of patients with epilepsy. Epilepsy Curr. 2024. https:\/\/doi.org\/10.1177\/15357597241242250.","journal-title":"Epilepsy Curr"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-026-01022-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-026-01022-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-026-01022-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T17:40:50Z","timestamp":1788889250000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-026-01022-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":44,"alternative-id":["1022"],"URL":"https:\/\/doi.org\/10.1007\/s40120-026-01022-x","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"assertion":[{"value":"29 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ilaria Sammarra, Adriana Saraceno, Iolanda Martino, Alessia Vono, Francesca Felicia Operto, Francesco Fortunato, and Antonio Gambardella have nothing to disclose.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by our institution\u2019s ethics committee and has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All participants provided informed consent to participate in the study and data were treated according to the European regulation GDPR n. 2016\/679.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}